Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
Investigational New Drugs|April 24, 2016
Pharmacokinetic drug interactions of the selective androgen receptor modulator GTx-024(Enobosarm) with itraconazole, rifampin, probenecid, celecoxib and rosuvastatinChristopher C Coss, Amanda Jones, James T DaltonMolecular and Cellular Endocrinology|June 19, 2017
Development of selective androgen receptor modulators (SARMs)Ramesh Narayanan, Christopher C Coss, James T DaltonArchives of Pharmacal Research|October 10, 2013
Effect of para halogen modification of S-3-(phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamides on metabolism and clearanceJuhyun Kim, Christopher C Coss, James T DaltonSteroids|June 20, 2014
Selective androgen receptor modulators as improved androgen therapy for advanced breast cancerChristopher C Coss, Amanda Jones, James T DaltonCurrent Opinion in Clinical Nutrition and Metabolic Care|March 19, 2011
Cancer cachexia therapy: a key weapon in the fight against cancerChristopher C Coss, Casey E Bohl, James T DaltonClinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2018
Cachectic Cancer Patients: Immune to Checkpoint Inhibitor Therapy?Christopher C Coss, Steven K Clinton, Mitch A PhelpsOrganic Letters|April 1, 2024
Function-Oriented Synthesis of Pentacyclic Triterpenoids and Discovery of an <i>ent</i>-Estrane as a Natural Product-Inspired Androgen Receptor AntagonistZachary D Stempel, Hanna S Radomska, Christopher C Coss, et al.Pharmaceutical Research|December 15, 2011
Alanine aminotransferase regulation by androgens in non-hepatic tissuesChristopher C Coss, Matt Bauler, Ramesh Narayanan, et al.Asian Journal of Andrology|January 11, 2014
Selective androgen receptor modulators for the treatment of late onset male hypogonadismChristopher C Coss, Amanda Jones, Michael L Hancock, et al.The Journal of Steroid Biochemistry and Molecular Biology|November 28, 2009
Mechanism of action of bolandiol (19-nortestosterone-3beta,17beta-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activitiesBarbara J Attardi, Stephanie T Page, Sheri A Hild, et al.Pageof 7